Thomas S. McHugh
Chief Financial Officer, K-V Pharmaceutical Co.
Companies
- Avadel PharmaceuticalsChief financial officer Dec 3, 2019 to now1
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
Avadel Pharmaceuticals AVDL0 shares2Feb 12, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Feb 12, 2026Returned to company 100,400 shares at $21.00 of Avadel Pharmaceuticals2
- Mar 5, 2025Granted 12,600 shares of Avadel Pharmaceuticals3
- Dec 13, 2024Bought 2,300 shares at $10.44 of Avadel Pharmaceuticals4
- Dec 11, 2024Bought 5,000 shares at $10.49 of Avadel Pharmaceuticals5
- Jan 16, 2024Bought 2,000 shares at $14.50 of Avadel Pharmaceuticals6
- Aug 14, 2023Bought 2,000 shares at $14.45 of Avadel Pharmaceuticals7
- Nov 29, 2022Bought 5,000 shares at $7.80 of Avadel Pharmaceuticals8
- May 27, 2022Bought 50,000 shares at $2.14 of Avadel Pharmaceuticals9
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3SEC EDGARForm 4 filed Mar 7, 2025
- 4SEC EDGARForm 4 filed Dec 16, 2024
- 5SEC EDGARForm 4 filed Dec 12, 2024
- 6SEC EDGARForm 4 filed Jan 16, 2024
- 7SEC EDGARForm 4 filed Aug 14, 2023
- 8SEC EDGARForm 4 filed Nov 30, 2022
- 9SEC EDGARForm 4 filed May 31, 2022